Bausch & Lomb Corp (BLCO) stock
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3026% below fair value
$21.09−0.05 (-0.24%)
Close on Nov 13, 2026Market cap $7.54BP/E –Yield –
Bausch & Lomb EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Bausch & Lomb's EPS for the twelve months ending Sep 30, 2026 was -$0.31. For fiscal 2025 it was -$1.02. The highest annual figure on record is $0.52 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.02 | – |
| FY2024 | Dec 31, 2024 | -$0.90 | – |
| FY2023 | Dec 31, 2023 | -$0.74 | -3800.0% |
| FY2022 | Dec 31, 2022 | $0.02 | -96.2% |
| FY2021 | Dec 31, 2021 | $0.52 | – |
| FY2020 | Dec 31, 2020 | -$0.05 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.09 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.04 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.20 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.16 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.08 | -900.0% |
| Q2 FY2025 | Jun 30, 2025 | -$0.18 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.60 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.01 | – |
| Q3 FY2024 | Sep 30, 2024 | $0.01 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.43 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.48 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.15 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.24 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.09 | -1000.0% |
| Q1 FY2023 | Mar 31, 2023 | -$0.26 | -533.3% |
| Q4 FY2022 | Dec 31, 2022 | $0.00 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | -$0.05 | -129.4% |
| Q2 FY2022 | Jun 30, 2022 | $0.01 | -92.3% |
| Q1 FY2022 | Mar 31, 2022 | $0.06 | -25.0% |
| Q4 FY2021 | Dec 31, 2021 | $0.15 | – |
| Q3 FY2021 | Sep 30, 2021 | $0.17 | – |
| Q2 FY2021 | Jun 30, 2021 | $0.13 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.08 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?